Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Citadel Securities LLC(0.4%),Citadel Securities Group LP(0.4%)等
04/25 17:56 (美东)
Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-TANG CAPITAL PARTNERS, LP(8.2%),Tang Capital Management, LLC(8.2%)等
04/19 06:12 (美东)
Marinus Pharmaceuticals | 8-K:Marinus Pharmicals提供第三阶段RAISE试验的最新情况,并公布了2024年第一季度的初步财务业绩
04/15 07:33 (美东)
Marinus Pharmaceuticals | DEFA14A:其他
04/04 08:05 (美东)
Marinus Pharmaceuticals | DEF 14A:股东委托书决议
04/04 08:05 (美东)
Marinus Pharmaceuticals | 8-K:重大事件
03/27 16:12 (美东)
Marinus Pharmaceuticals | 4:持股变动声明-高管 Braunstein Scott
03/27 11:59 (美东)
Marinus Pharmaceuticals | 10-K:年度报表
03/05 16:19 (美东)
Marinus Pharmaceuticals | 8-K:Marinus Pharmicals提供最新业务并报告2023年第四季度和全年财务业绩
03/05 16:10 (美东)
Marinus Pharmaceuticals | 4:持股变动声明-高管 MANNING MARTHA E
02/22 16:08 (美东)
Marinus Pharmaceuticals | 4:持股变动声明-高管 Shafer Christina
02/22 16:08 (美东)
Marinus Pharmaceuticals | 4:持股变动声明-高管 Hulihan Joseph
02/21 16:12 (美东)
Marinus Pharmaceuticals | 4:持股变动声明-高管 Pfanstiel Steven
02/21 16:10 (美东)
Marinus Pharmaceuticals | 4:持股变动声明-高管 Braunstein Scott
02/21 16:09 (美东)
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-LION POINT CAPITAL, LP(3.9%),LION POINT HOLDINGS GP, LLC(3.9%)等
02/14 17:41 (美东)
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(5.96%),Cormorant Global Healthcare GP, LLC(5.96%)等
02/14 15:13 (美东)
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Eventide Asset Management, LLC(8.30%),Finny Kuruvilla, M.D. Ph. D.(8.30%)等
02/14 12:22 (美东)
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(0.9%),Point72 Capital Advisors, Inc.(0.9%)等
02/14 10:14 (美东)
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(5.8%),Behzad Aghazadeh(5.8%)
02/14 09:07 (美东)
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(9.99%),Aaron Cowen(9.99%)等
02/13 12:15 (美东)
暂无数据
暂无数据